On the public citation graph
Investigation of dual AChE/MAO inhibitory activities of new morpholine and piperazine structured compounds
0 signed · 38 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/alz.13809openalex-snapshot
2024 Alzheimer's disease facts and figures
inferredcites →https://doi.org/10.1002/ardp.201800309openalex-snapshot
Potent and highly selective dual‐targeting monoamine oxidase‐B inhibitors: Fluorinated chalcones of morpholine versus imidazole
inferredcites →https://doi.org/10.1002/ardp.201900177openalex-snapshot
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
inferredcites →https://doi.org/10.1002/ardp.202100450openalex-snapshot
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors
inferredcites →https://doi.org/10.1007/s11356-021-13320-yopenalex-snapshot
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
inferredcites →https://doi.org/10.1016/j.bcp.2013.12.024openalex-snapshot
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
inferredcites →https://doi.org/10.1016/j.bioorg.2018.11.016openalex-snapshot
Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors
inferredcites →https://doi.org/10.1016/j.bioorg.2018.12.019openalex-snapshot
In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors
inferredcites →https://doi.org/10.1016/j.bioorg.2021.104917openalex-snapshot
Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies
inferredcites →https://doi.org/10.1016/j.bioorg.2021.105038openalex-snapshot
Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity
inferredcites →https://doi.org/10.1016/j.bmcl.2016.10.041openalex-snapshot
Design, synthesis, and AChE inhibitory activity of new benzothiazole–piperazines
inferredcites →https://doi.org/10.1016/j.cbi.2022.110227openalex-snapshot
Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction
inferredcites →https://doi.org/10.1016/j.ejmech.2016.10.042openalex-snapshot
Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes
inferredcites →https://doi.org/10.1016/j.ejmech.2017.12.013openalex-snapshot
Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible h MAO-A inhibitors
inferredcites →https://doi.org/10.1016/s0197-4580(00)00100-7openalex-snapshot
Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease
inferredcites →https://doi.org/10.1021/acsomega.2c06906openalex-snapshot
Design, Synthesis, and In Vitro and In Silico Approaches of Novel Indanone Derivatives as Multifunctional Anti-Alzheimer Agents
inferredcites →https://doi.org/10.1073/pnas.0508575102openalex-snapshot
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
inferredcites →https://doi.org/10.1080/07391102.2022.2033643openalex-snapshot
Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors
inferredcites →https://doi.org/10.1080/10426507.2016.1259228openalex-snapshot
Anticholinesterase activity screening of some novel dithiocarbamate derivatives including piperidine and piperazine moieties
inferredcites →https://doi.org/10.1080/14756366.2020.1842390openalex-snapshot
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
inferredcites →https://doi.org/10.1093/ajcn/71.2.621sopenalex-snapshot
Oxidative stress and Alzheimer disease
inferredcites →https://doi.org/10.1097/01.wad.0000201854.62116.d7openalex-snapshot
Early-Life Risk Factors for Alzheimer Disease
inferredcites →https://doi.org/10.1111/jphp.13244openalex-snapshot
TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s-like neuropathology
inferredcites →https://doi.org/10.2174/1381612043386509openalex-snapshot
Acetylcholinesterase Inhibition in Alzheimers Disease
inferredcites →https://doi.org/10.2174/1389557513666131119201353openalex-snapshot
Donepezil: An Important Prototype to the Design of New Drug Candidates for Alzheimer’s Disease
inferredcites →https://doi.org/10.3390/cryst10080637openalex-snapshot
Design, Synthesis, and Biological Activity Evaluation of New Donepezil-Like Compounds Bearing Thiazole Ring for the Treatment of Alzheimer’s Disease
inferredcites →https://doi.org/10.3390/ijms24119583openalex-snapshot
New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
inferredcites →https://doi.org/10.3390/molecules23082033openalex-snapshot
Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
inferredcites →https://doi.org/10.3390/molecules24050861openalex-snapshot
Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives
inferredcites →https://doi.org/10.3390/molecules24132392openalex-snapshot
Synthesis and AChE Inhibitory Activity of Novel Thiazolylhydrazone Derivatives
inferredcites →https://doi.org/10.3390/ph16010083openalex-snapshot
Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.73.e187083zenodo-depositor-declared
Volatile profile and multitarget in silico evaluation of Agrimonia eupatoria L. essential oil and infusion
inferred← citeshttps://doi.org/10.1007/s11030-026-11499-1openalex-snapshot
Rational drug design and synthesis of novel bioactive molecules with oxygen heterocycles, including AChE and BChE inhibitory properties and SAR studies
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.109364openalex-snapshot
A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects
inferred← citeshttps://doi.org/10.1080/17568919.2025.2515812openalex-snapshot
Therapeutic potential of morpholine-based compounds in neurodegenerative diseases: SAR insights and analysis
inferred← citeshttps://doi.org/10.1111/cbdd.70347openalex-snapshot
Structure‐Guided Optimization of 1,2,4‐Triazole‐Thione‐Based Mannich Derivatives as Dual‐Target Modulators: AChE / MAO ‐B
inferred← citeshttps://doi.org/10.3390/plants15121765openalex-snapshot
Comparative Profiling and In Silico Multitarget Analysis of Volatile Constituents from Sambucus ebulus L. Dried Fruits
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.